首页> 外文期刊>Panminerva medica >The additional diagnostic value of a single-session combined scintigraphic and ultrasonographic examination in patients with thyroid and parathyroid diseases.
【24h】

The additional diagnostic value of a single-session combined scintigraphic and ultrasonographic examination in patients with thyroid and parathyroid diseases.

机译:单次联合闪烁显像和超声检查对甲状腺和甲状旁腺疾病患者的附加诊断价值。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: The aim of this study was to investigate the diagnostic efficacy and the clinical impact of scintigraphy combined with ultrasonography (USG) in the management of thyroid and parathyroid disorders in a large series of patients. METHODS: A total of 387 consecutive patients referred to the Nuclear Medicine Department of Hacettepe University in the period from January to September 2007 for investigating a thyroid (N. 339 patients: 232 females and 107 males, mean age+/-SD=48.9+/-13.6 years) or a parathyroid disease (N. 48 patients: 34 females and 14 males, mean age+/-SD=47.4+/-9.6 years) were prospectively evaluated, systematically performing both scintigraphy and USG in a single-day session. All the examinations were independently reviewed by two nuclear medicine physicians; in cases of discrepancy (3%) a final diagnosis was reached by consensus. For thyroid pathologies, USG results were considered to provide additional diagnostic information over scintigraphy: 1) if more nodules were identified; 2) if an irregular hyperactive area at scintigraphy suspicious for the presence of a nodule was clearly characterized at USG; 3) if a nodule missed at scintigraphy because of small size (<1 cm) was well depicted at USG, thus allowing an USG-guided fine needle aspiration cytology (FNAC) to reach a final diagnosis. For parathyroid pathologies, USG was considered to provide additional diagnostic information over scintigraphy if a low intensity radiotracer retention from the parathyroid suspected of being a parathyroid enlargement was clearly depicted at USG. In thyroid diseases, scintigraphy was considered to provide additional diagnostic information over USG, if the functional status of a diffuse or uni- or multi-nodular goiter were clearly defined at scintigraphy. In parathyroid diseases, scintigraphy was considered to provide additional diagnostic information over USG, if the differential diagnosis between a lymph node or a muscle or a vessel depicted at USG was clearly defined as a parathyroid enlargement at scintigraphy. Lastly, the clinical impact of the single-day combined scintigraphic/USG protocol was evaluated. RESULTS: USG. In the thyroid diseases group, USG was particularly useful: 1) to detect additional nodules in glands with suppressed thyroid tissue; 2) to disclose small thyroid nodules (<1 cm) in which it was possible to perform a USG-FNAC. In the parathyroid diseases group, USG was particularly useful for the detection of parathyroid enlargements not visualized at scintigraphy because characterized by a rapid wash-out of the radiotracer and thus by a low radioactivity intensity in the delayed scintigraphic images. Scintigraphy. In the thyroid diseases group, scintigraphy was particularly useful: 1) to diagnose a diffuse hyperfunctioning thyroid gland, and to differentiate in multinodular goiters the hyper- from the hypo-functioning nodules. In the hyperparathyroid diseases group, scintigraphy was particular useful in making a differential diagnosis between a true parathyroid enlargement vs. a lymph node or a muscle or a vessel as depicted at USG, and in cases with deeply or ectopically-positioned parathyroid glands. Combined imaging approach. Combined interpretation provided additional benefit in 225 of 339 patients (64.4%). Overall, using the combined scintigraphic/USG single-day protocol, in the thyroid diseases group the therapeutic strategy (drug therapy vs radioiodine therapy vs surgery) was changed in 176/225 patients (78.2%, P<0.001 by chi(2) of Pearson), and in the parathyroid disease group the therapeutic strategy (medical therapy vs surgery) was changed in 18/48 patients (37.5%, P<0.01 by c2 test of Pearson). CONCLUSION: In agreement with some previous published exsperiences, the combined single-day scintigraphic/USG protocol systematically adopted in a large series of consecutive patients with thyroid and parathyroid diseases, enrolled in a limited period of time, proved to significantly increase the global
机译:目的:本研究的目的是探讨闪烁显像结合超声检查(USG)在一系列患者甲状腺和甲状旁腺疾病管理中的诊断效力和临床影响。方法:2007年1月至2007年9月,共有387例患者连续转诊至Hacettepe大学核医学系进行甲状腺检查(N. 339例患者:232例女性和107例男性,平均年龄+/- SD = 48.9 + / -13.6岁)或甲状旁腺疾病(N. 48例:34例女性和14例男性,平均年龄+/- SD = 47.4 +/- 9.6岁)进行了前瞻性评估,并在一天的时间内系统地进行了闪烁显像和USG检查。所有检查均由两名核医学医师独立审查;在差异(3%)的情况下,以共识达成最终诊断。对于甲状腺病理,USG结果被认为可提供比闪烁显像更多的诊断信息:1)如果发现更多结节; 2)在USG上是否明确地发现了可疑结节的闪烁显像的不规则多动区; 3)如果在USG上很好地描绘了因小尺寸(<1 cm)而在闪烁显像术上遗漏的结节,则可以通过USG指导的细针穿刺细胞学检查(FNAC)进行最终诊断。对于甲状旁腺病理,如果在USG上明确描绘了疑似甲状旁腺肿大的甲状旁腺的低强度放射性示踪剂保留,则USG被认为比闪烁显像术可提供更多的诊断信息。在甲状腺疾病中,如果在闪烁显像仪上明确定义了弥散性或单结节或多结节性甲状腺肿的功能状态,则闪烁显像仪可提供比USG更多的诊断信息。在甲状旁腺疾病中,如果USG所描绘的淋巴结或肌肉或血管之间的鉴别诊断明确定义为闪烁显像时甲状旁腺肿大,则闪烁显像术可被认为比USG提供更多的诊断信息。最后,评估了单日联合闪烁显像/ USG方案的临床影响。结果:USG。在甲状腺疾病组中,USG特别有用:1)在甲状腺组织被抑制的腺体中发现其他结节; 2)公开其中可以进行USG-FNAC的小甲状腺结节(<1 cm)。在甲状旁腺疾病组中,USG特别适用于检测闪烁显像时未发现的甲状旁腺肿大,因为其特点是放射性示踪剂会被快速冲洗掉,因此在延迟的闪烁显像图像中放射性强度较低。显像术。在甲状腺疾病组中,闪烁显像特别有用:1)诊断弥漫性甲状腺功能亢进,并在多结节性甲状腺肿中区分功能亢进的结节。在甲状旁腺功能亢进疾病组中,闪烁显影法在进行真正的甲状旁腺肿大与淋巴结或肌肉或血管的鉴别诊断时特别有用,如在USG所描绘的,以及在甲状旁腺位置深或异位的情况下。组合成像方法。联合解释为339例患者中的225例(64.4%)提供了额外的益处。总体而言,使用联合闪烁显像/ USG单日方案,在甲状腺疾病组中,有176/225例患者改变了治疗策略(药物治疗vs放射碘治疗vs外科手术)(78.2%,P <0.001,经chi(2))。皮尔逊(Pearson),在甲状旁腺疾病组中,对18/48例患者的治疗策略(药物治疗与手术)进行了更改(37.5%,通过皮尔森c2检验的P <0.01)。结论:与先前发表的一些经验相一致,在有限的时间范围内入组的一系列连续的甲状腺和甲状旁腺疾病患者中系统地采用了联合单日闪烁显像/ USG方案,事实证明该方案显着增加了总体

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号